Technical Analysis for RSLBF - Raysearch Laboratori

Grade Last Price % Change Price Change
grade C 11.16 -0.36% -0.0400
RSLBF closed down 0.36 percent on Thursday, December 19, 2019, on 9 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical RSLBF trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Narrow Range Bar Range Contraction -0.36%
Wide Bands Range Expansion -0.36%
Down 3 Days in a Row Weakness -0.36%
Older signals for RSLBF ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


RaySearch Laboratories AB (publ) operates as a medical technology company that develops software solutions for cancer treatment in North America, Asia, Europe, and internationally. It develops and markets RayStation, a treatment planning system to radiation therapy centers for treatment activities, such as automated planning, adaptive therapy, multi-criteria and speed and advanced optimization, physician's toolbox, machine learning, VMAT, IMRT, 3D-CRT, virtual simulation, electron beam therapy, tomotherapy and stereotactic planning, proton therapy, and carbon ion therapy. The company also develops RayPlan, a solution for supporting a range of treatment planning activities; and RayCare, a machine learning oncology information system for the treatment of cancer comprising oncology treatment activities, including digital oncology workflows, rule-based scheduling, state-of-the-art software platform, enterprise-wide integration, adaptive therapy, and data handling and machine learning. In addition, it provides training courses, as well as customer support services. The company sells its products directly to end customers, as well as through partners and distributors. RaySearch Laboratories AB (publ) has strategic alliances with Princess Margaret Hospital for the advancement of adaptive radiation therapy; University of California; University Medical Center Groningen; Iridium Kankernetwerk; and University of Texas MD Anderson Cancer Center to advance radiation therapy of cancer. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Medicine Health Medical Specialties Cancer Software Solutions Treatment Of Cancer Simulation Medical Technology Oncology Radiation Therapy Medical Physics Software Platform Machine Learning Radiation Therapy Customer Support Services Cancer Treatment University Of California Proton Therapy Texas Md Anderson Cancer Center University Of Texas A Solution University Of Texas Md Anderson Cancer Center Radiation Treatment Planning

Is RSLBF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 28.0
52 Week Low 8.0
Average Volume 1,168
200-Day Moving Average 0.0000
50-Day Moving Average 13.6179
20-Day Moving Average 13.3535
10-Day Moving Average 14.9660
Average True Range 1.5217
ADX 15.5
+DI 43.1214
-DI 54.0489
Chandelier Exit (Long, 3 ATRs ) 14.9349
Chandelier Exit (Short, 3 ATRs ) 12.5651
Upper Bollinger Band 19.8297
Lower Bollinger Band 6.8773
Percent B (%b) 0.33
BandWidth 96.9963
MACD Line -0.2075
MACD Signal Line 0.1958
MACD Histogram -0.4033
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.1600
Resistance 3 (R3) 11.1600 11.1600 11.1600
Resistance 2 (R2) 11.1600 11.1600 11.1600 11.1600
Resistance 1 (R1) 11.1600 11.1600 11.1600 11.1600 11.1600
Pivot Point 11.1600 11.1600 11.1600 11.1600 11.1600
Support 1 (S1) 11.1600 11.1600 11.1600 11.1600 11.1600
Support 2 (S2) 11.1600 11.1600 11.1600 11.1600
Support 3 (S3) 11.1600 11.1600 11.1600
Support 4 (S4) 11.1600